| Literature DB >> 26420727 |
Masahiko Ayaki1, Takeo Nagura2, Yoshiaki Toyama2, Kazuno Negishi1, Kazuo Tsubota1.
Abstract
The aim of the present study was to measure gait velocity in cataract and simulated patients. The study was performed on 239 cataract patients, 115 age-matched subjects, and 11 simulated patients. We measured gait velocity and analyzed gait using a three-dimensional motion analysis system. Mean gait velocity before and 2 and 7 months after cataract surgery was 0.91 ± 0.19, 1.04 ± 0.21, and 1.06 ± 0.21 m/s, respectively, for males and 0.84 ± 0.22, 0.91 ± 0.24, and 0.92 ± 0.25 m/s, respectively, for females. The increase after surgery was significant in both groups at 7 months (P < 0.05). Gait velocity was significantly slower in cataract patients compared with controls before surgery, but no longer different after surgery. In simulated patients, mean velocity was 87.0 ± 11.4% of normal vision with a 3° visual field and 92.4 ± 12.3% of normal when counting fingers. Initial velocity was 89.1 ± 14.6% of normal vision with a 3° visual field and 92.7 ± 11.6% of normal when counting fingers. There was a significant difference between normal and impaired visual function (P < 0.05). The results demonstrate the close relationship between visual function and gait in cataract patients and simulated patients.Entities:
Mesh:
Year: 2015 PMID: 26420727 PMCID: PMC4588563 DOI: 10.1038/srep14595
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Simulation goggles and simulated visual field.
“Simulated patients” wore goggles (top left) to simulate reduced visual function to the vision of 20/600. Representative results of visual field analysis (Humphrey Field Analyzer 30-2 program; Carl Zeiss, Jena, Germany) with goggles restricting the visual field to 3° show a successful simulation effect (bottom left and center). Motion analyses were performed using a motion capture system comprising eight cameras and a force plate (right).
Demographics and gait velocity in cataract patients.
| All patients | Male | Female | ||
|---|---|---|---|---|
| Gait velocity (m/s) | ||||
| Before surgery | 0.87 ± 0.21 | 0.91 ± 0.19 | 0.84 ± 0.22 | 0.01** |
| 2 months after surgery | 0.96 ± 0.23 | 1.04 ± 0.21 | 0.91 ± 0.24 | 0.04** |
| 7 months after surgery | 0.98 ± 0.24* | 1.06 ± 0.21* | 0.92 ± 0.25* | 0.04** |
| Model 1: systemic parameters | ||||
| No. patients | 239 | 95 | 144 | |
| Age (years) | 74.4 ± 8.0 | 72.1 ± 8.8 | 76.0 ± 7.1 | <0.001** |
| Height (cm) | 155 ± 9 | 163 ± 6 | 149 ± 6 | <0.001** |
| Weight (kg) | 56.2 ± 11.4 | 63.4 ± 11.0 | 51.3 ± 8.8 | <0.001** |
| BMI (kg/m2) | 23.3 ± 3.5 | 23.7 ± 3.6 | 22.9 ± 3.4 | 0.107 |
| Diabetes (%) | 23.8 | 23.7 | 22.9 | 0.310 |
| SBP (mmHg) | 131.3 ± 18.1 | 129.8 ± 18.7 | 132.4 ± 17.6 | 0.326 |
| Model 2: vision-related parameters | ||||
| VFQ-25 score | ||||
| Before surgery | 64.3 ± 16.4 | 68.4 ± 13.8 | 61.4 ± 17.6 | <0.001** |
| After surgery | 79.8 ± 12.5* | 80.6 ± 10.8* | 79.4 ± 13.6* | 0.477 |
| Visual acuity before surgery | ||||
| In the better eye | 0.16 ± 0.29 | 0.11 ± 0.19 | 0.20 ± 0.34 | 0.01** |
| In the worse eye | 0.63 ± 0.80 | 0.58 ± 0.68 | 0.67 ± 0.87 | 0.390 |
| Visual acuity 2 months after surgery | ||||
| In the better eye | −0.03 ± 0.09* | −0.05 ± 0.06* | −0.02 ± 0.10* | 0.003** |
| In the worse eye | 0.11 ± 0.46* | 0.09 ± 0.31* | 0.12 ± 0.53* | 0.579 |
| % Hyperopic (either eye ≥ +3·00D) | 7.1 | 7.4 | 6.9 | 0.900 |
| % Myopic (either eye ≤ −3·00D) | 25.5 | 31.6 | 21.5 | 0.081 |
| Model 3: type of cataract opacity | ||||
| Posterior subcapsular | 38.5% | 49.5% | 31.3% | 0.012** |
| Nuclear (>Grade 2) | 23.4% | 24.7% | 22.4% | 0.721 |
| Central cortical | 47.5% | 42.3% | 51.0% | 0.193 |
Data are given as the mean ± SD or as the percentage of patients in each group, as appropriate. *P < 0.05 compared with before surgery (paired t-test); **P < 0.05 for male versus female (unpaired t-test).
BMI, body mass index; SBP, systolic blood pressure; LogMAR, logarithm of the minimum angle of resolution; VFQ-25, visual function questionnaire 25.
Figure 2(a) Four-meter gait velocity in male (closed symbols) and female (open symbols) cataract patients before and 2 and 7 months after surgery. Gait velocity increased continuously up to 7 months after surgery with statistical significance in both groups (*P < 0.05 vs preoperative velocity, paired t-test). (b) Scatter plot of gait velocity versus age of cataract patients before (closed symbols) and 2 months after (open symbols) surgery. Note that age was strongly correlated with gait velocity. The regression lines were y = −0.0136x + 1.8845; R2 = 0.2753 (solid line) for before surgery and y = −0.0134x + 1.9175; R2 = 0.2743 (dashed line) for after surgery.
Stepwise multiple regression analysis of gait velocity and related parameters.
| Preoperative gait velocity | ∆Gait velocityA | |||
|---|---|---|---|---|
| β | Β | |||
| Model 1: vision-related parameters | ||||
| LogMAR in the better eye | −0.11 | 0.06 | 0.02 | 0.79 |
| LogMAR in the worse eye | −0.12 | 0.04* | 0.07 | 0.29 |
| ∆LogMAR in the worse eye | — | — | 0.55 | 0.04* |
| Myopia > −3.0D in either eye | 0.02 | 0.70 | 0.08 | 0.27 |
| Preoperative VFQ-25 score | 0.28 | 0.00* | −0.05 | 0.46 |
| ∆VFQ-25 score | — | — | 0.04 | 0.55 |
| Model 2: cataract opacity | ||||
| Nuclear sclerosis | −0.09 | 0.12 | 0.02 | 0.74 |
| Posterior subcapsular | −0.07 | 0.30 | 0.20 | 0.01* |
| Central cortical | 0.09 | 0.19 | 0.02 | 0.81 |
| Model 3: systemic parameters | ||||
| Age | −0.52 | 0.00* | −0.06 | 0.50 |
| Sex | 0.19 | 0.01* | −0.02 | 0.72 |
| Height | 0.39 | 0.00* | −0.12 | 0.32 |
| BMI | −0.05 | 0.41 | −0.12 | 0.11 |
| Diabetes | −0.03 | 0.68 | 0.02 | 0.81 |
| SBP | −0.07 | 0.31 | 0.11 | 0.14 |
*P < 0.05, Pearson’s product–moment correlation.
Male = 1, female = 0, diabetic = 1, non-diabetic = 0.
AChanges in values (Δ) were calculated by subtracting preoperative values from values obtained 2 months after surgery. All values were adjusted for age and sex.
LogMAR, logarithm of the minimum angle of resolution; VFQ-25, visual function questionnaire 25; BMI, body mass index; SBP, systolic blood pressure.
Figure 3(a) Initial velocity (mean velocity during the first 0.1 s of the first step) and (b) mean velocity in subjects in whom low visual function was simulated by reducing visual acuity to 20/600 and counting fingers, and reducing the visual field to 3°. Note that gait velocity was correlated with visual function. There was a significant difference between values obtained under normal vision conditions (visual acuity > 20/15) and each simulated low-vision condition (*P < 0.05, paired t-test).